| Age-sensitive response of systemic AAV-mediated gene therapy in a newly characterized feline model of mucolipidosis II | 2025 |
| Familial Narcolepsy in Dogo Argentino Dogs Is Caused by a Tandem Duplication Mutation in HCRTR2 | 2025 |
| Single Cell Transcriptomic Profiling of MYBPC3-Associated Hypertrophic Cardiomyopathy Across Species Reveals Conservation of Biological Process But Not Gene Expression | 2025 |
| Transcriptomic and genetic profiling in a spontaneous non-human primate model of hypertrophic cardiomyopathy and sudden cardiac death | 2024 |
| Correlation, agreement and concordance of cardiac output estimated by transthoracic ultrasound and transesophageal Doppler with pulmonary artery thermodilution in anesthetized cats | 2024 |
| Platelet hyperresponsiveness and increased platelet-neutrophil aggregates in dogs with myxomatous mitral valve disease and pulmonary hypertension | 2024 |
| Evaluation of clopidogrel response in healthy cats using a novel viscoelastic test and thromboelastography | 2024 |
| A variant in the 5’UTR of ERBB4 is associated with lifespan in Golden Retrievers | 2024 |
| Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy | 2024 |
| A novel ITGA2B double cytosine frameshift variant (c.1986_1987insCC) leads to Glanzmann’s thrombasthenia in a cat | 2024 |
| Sex-specific differences and predictors of echocardiographic measures of diastolic dysfunction in rhesus macaques (Macaca mulatta) | 2023 |
| Naturally occurring canine laminopathy leading to a dilated and fibrosing cardiomyopathy in the Nova Scotia Duck Tolling Retriever. | 2023 |
| The Genetics of Canine Pulmonary Valve Stenosis | 2023 |
| The Role of Personalized Medicine in Companion Animal Cardiology | 2023 |
| Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trial | 2023 |
| No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan-induced inhibition of platelet aggregation response | 2023 |
| Subvalvular Aortic Stenosis: Learning From Human and Canine Clinical Research. | 2023 |
| Multi-Omic, Histopathologic, and Clinicopathologic Effects of Once-Weekly Oral Rapamycin in a Naturally Occurring Feline Model of Hypertrophic Cardiomyopathy: A Pilot Study | 2023 |
| Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats | 2023 |
| Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C | 2023 |
| Evaluation of autoantibodies to desmoglein-2 in dogs with and without cardiac disease | 2023 |
| Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism | 2023 |
| Nonhuman primate genetic models for the study of rare diseases | 2023 |
| Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy | 2023 |
| Pharmacokinetics of a single dose of Aficamten (CK-274) on cardiac contractility in a A31P MYBPC3 hypertrophic cardiomyopathy cat model | 2023 |